PP
GILD icon

PDS Planning’s Gilead Sciences GILD Stock Holding History

PDS Planning’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$754K Sell
5,965
-136
-2% -$17.9K 0.04% 215
2026
Q1 		$850K Buy
6,101
+169
+3% +$23.7K 0.06% 168
2025
Q4 		$728K Buy
5,932
+18
+0.3% +$2.19K 0.05% 188
2025
Q3 		$656K Buy
5,914
+124
+2% +$14.1K 0.05% 197
2025
Q2 		$642K Buy
5,790
+592
+11% +$63K 0.05% 194
2025
Q1 		$582K Buy
5,198
+528
+11% +$54.5K 0.05% 189
2024
Q4 		$431K Buy
4,670
+170
+4% +$15.3K 0.04% 216
2024
Q3 		$377K Buy
4,500
+433
+11% +$33K 0.03% 246
2024
Q2 		$279K Sell
4,067
-695
-15% -$46.4K 0.03% 273
2024
Q1 		$349K Buy
4,762
+336
+8% +$25.8K 0.04% 220
2023
Q4 		$359K Buy
4,426
+182
+4% +$14.2K 0.04% 202
2023
Q3 		$318K Sell
4,244
-43
-1% -$3.31K 0.04% 205
2023
Q2 		$330K Buy
4,287
+84
+2% +$6.7K 0.04% 195
2023
Q1 		$349K Buy
4,203
+1,590
+61% +$132K 0.05% 169
2022
Q4 		$224K Buy
+2,613
New +$207K 0.04% 183

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PDS Planning's GILD Position: Q2 2026 in Review

PDS Planning reduced its Gilead Sciences (GILD) stake by 2.2% in Q2 2026, selling an estimated $17.9K and leaving 5,965 shares worth $754K. The position accounts for 0.04% of the portfolio, ranked #215.

PDS Planning first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $850K in Q1 2026. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • PDS Planning held 5,965 shares of Gilead Sciences worth $754K as of Q2 2026.
  • PDS Planning sold 136 Gilead Sciences shares in Q2 2026, an estimated $17.9K.
  • Gilead Sciences made up 0.04% of PDS Planning's portfolio in Q2 2026, its #215 holding.
  • PDS Planning first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • PDS Planning's Gilead Sciences position peaked at $850K in Q1 2026.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on PDS Planning's 13F filing for Q2 2026, filed 5 Aug 2026.